Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B

被引：0
|
作者：
Chang, Ting-Tsung
Chao, You-Chen
Wu, Shun-Sheng
Tan, Chee Kia
Rosmawati, Mohamed
Lee, Alice
George, Jacob
Brett-Smith, Helena
Zink, Richard
Neo, Boon-Leong
机构：
[1] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[2] Tri Serv Gen Hosp, Taipei, Taiwan
[3] Changhua Christian Hosp Hosp, Changhua, Taiwan
[4] Singapore Gen Hosp, Singapore 0316, Singapore
[5] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia
[6] Concord Repatriation Gen Hosp, Concord, NSW, Australia
[7] Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead, NSW, Australia
[8] Bristol Myers Squibb Pharmaceut Res Inst, Wallingford, CT USA
[9] Bristol Myers Squibb Pharmaceut Res Inst, Singapore, Singapore
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [41] Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
    Buti, Maria
    Morillas, Rosa M.
    Perez, Juan
    Prieto, Martin
    Sola, Ricard
    Palau, Antonio
    Diago, Moises
    Bonet, Lucia
    Gallego, Adolfo
    Garcia-Samaniego, Javier
    Testillano, Milagros
    Rodriguez, Manuel
    Castellano, Gregorio
    Gutierrez, Maria L.
    Delgado, Manuel
    Mas, Antoni
    Romero-Gomez, Manuel
    Calleja, Jose L.
    Gonzalez-Guirado, Agustina
    Arenas, Juan I.
    Garcia-Buey, Luisa
    Andrade, Raul
    Gila, Ana
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 46 - 54
  • [42] Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China
    Guangbi Yao
    Xiaqiu Zhou
    Daozheng Xu
    Baoen Wang
    Hong Ren
    Jessica Liu
    Dong Xu
    Laurie MacDonald
    Hepatology International, 2007, 1 : 373 - 381
  • [43] Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China
    Yao, Guangbi
    Zhou, Xiaqiu
    Xu, Daozheng
    Wang, Baoen
    Ren, Hong
    Liu, Jessica
    Xu, Dong
    MacDonald, Laurie
    HEPATOLOGY INTERNATIONAL, 2007, 1 (03) : 373 - 381
  • [44] Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation
    Hsu, Yao-Chun
    Mo, Lein-Ray
    Chang, Chi-Yang
    Perng, Daw-Shyong
    Tseng, Cheng-Hao
    Lo, Gin-Ho
    Tai, Chih-Min
    Lin, Chih-Wen
    Hsu, Chia-Chang
    Hsu, Chuan-Yuan
    Huang, Shih-Che
    Lin, Jaw-Town
    ANTIVIRAL THERAPY, 2012, 17 (04) : 605 - 612
  • [45] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [46] CccDNA reduction in chronic hepatitis B patients treated with entecavir versus lamivudine
    Co, Jonard
    Sollano, Jose
    Nilo, Grace
    Antonio, Felinor
    Dy, Frederick
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A9 - A10
  • [47] ENTECAVIR VERSUS LAMIVUDINE IN THE TREATMENT OF CHRONIC HEPATITIS B PATIENTS WITH HEPATIC DECOMPENSATION
    Hsu, Yao-Chun
    Mo, Lein-Ray
    Chang, Chi-Yang
    Tseng, Cheng-Hao
    Lin, Jaw-Town
    HEPATOLOGY, 2011, 54 : 1009A - 1010A
  • [48] Long term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)
    Mochida, S.
    Takaguchi, K.
    Yokosuka, O.
    Fujioka, S.
    Hayashi, N.
    Shindo, M.
    Chayama, K.
    Toyota, J.
    Ishikawa, H.
    Seriu, T.
    Omata, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S262 - S262
  • [49] Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
    Lai, CL
    Rosmawati, M
    Lao, J
    Van Vlierberghe, H
    Anderson, FH
    Thomas, N
    Dehertogh, D
    GASTROENTEROLOGY, 2002, 123 (06) : 1831 - 1838
  • [50] The antiviral effects of entecavir (ETV) versus lamivudine (LVD) treatment in HBeAg-negative nucleos(t)ide-naive Korean chronic hepatitis B (CHB) patients: week 24 analysis
    Lee, K. S.
    Kwon, Y-O
    Suh, D. J.
    Um, S-H
    Kim, B-H
    Paik, S. W.
    Heo, J.
    Lee, H-J
    Kim, D. J.
    Kim, T. H.
    Lee, Y-S
    Byun, K. S.
    Kim, D. G.
    Lee, M. S.
    Wilber, R.
    Brett-Smith, H.
    Lee, C-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A179 - A179
12345